Drug detailing in academic medical centers: Regulating for the right reasons, with the right evidence, at the right time

American Journal of Bioethics

Volumn 10, Issue 1, 2010, Pages 21-23

  Steinman, Michael A ^a   Schillinger, Dean ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; ARTICLE; CLINICAL PRACTICE; CONFLICT OF INTEREST; DECISION MAKING; DRUG INDUSTRY; ECONOMICS; ETHICS; GIFT GIVING; HUMAN; MEDICAL ETHICS; MEDICAL SOCIETY; PHYSICIAN; POLICY; PRESCRIPTION; TRUST; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADVERTISING AS TOPIC; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG PRESCRIPTIONS; ETHICS, MEDICAL; GIFT GIVING; HUMANS; JUDGMENT; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PUBLIC POLICY; SOCIETIES, MEDICAL; TRUST; UNITED STATES;

EID: 75149194718     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160903441103     Document Type: Article

References (11)

1. Association of American Medical Colleges. 2007. The scientific basis of influence and reciprocity: A symposium, 2007. Washington, DC: AAMC.
2. Association of American Medical Colleges. 2008. Industry funding of medical education: Report of an AAMC task force. Available at: http://services.aamc.org/publications/showfile.cfm?file=version114.pdf&prd_id=232, accessed December 7, 2009.
3. Fugh-Berman, A., and S. Ahari. 2007. Following the script: How drug reps make friends and influence doctors. PLoS Medicine 4(4): e150.
4. Huddle, T. 2010. The pitfalls of deducing ethics from behavioral economics: Why the Association of American Medical Colleges is wrong about pharmaceutical detailing. American Journal of Bioethics 10(1): 1-8.
5. Majumdar, S. R., F. A. McAlister, and S. B. Soumerai. 2003. Synergy between publication and promotion: Comparing adoption of new evidence in Canada and the United States. American Journal of Medicine 115(6): 467-472.
6. Manchanda, P., and E. Honka. 2005. The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review. Yale Journal of Health, Policy, Law, and Ethics 5(2): 785-822.
7. Rothman, D. J. 2000. Medical professionalism-Focusing on the real issues. New England Journal of Medicine 342(17): 1283-1286.
8. Steinman, M. A., L. A. Bero, M. M. Chren, and C. S. Landefeld. 2006. Narrative review: The promotion of gabapentin: An analysis of internal industry documents. Annals of Internal Medicine 145(4): 284-293.
9. Waxman, H. A. 2005. The marketing of Vioxx to physicians. Washington, DC: Committee on Government Reform, United States House of Representatives.
10. Wazana, A. 2000. Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association 283(3): 373-380.
11. Zipkin, D. A., and M. A. Steinman. 2005. Interactions between pharmaceutical representatives and doctors in training. A thematic review. Journal of General Internal Medicine 20(8): 777-786.